Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for pfizer
Roche shields itself from a UK Arrow: Pfizer v Roche Roche shields itself from a UK Arrow: Pfizer v Roche Reviewed by Dr Rose Hughes on Thursday, June 27, 2019 Rating: 5
Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans Amgen, Pfizer, Alphabet and Uber face up to trade secrets in biosimilars, self driving cars and product launch plans Reviewed by Annsley Merelle Ward on Thursday, March 09, 2017 Rating: 5
Never Too Late: If you missed the IPKat last week! Never Too Late: If you missed the IPKat last week! Reviewed by Tian Lu on Wednesday, November 02, 2016 Rating: 5
Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again Court of Appeal on Pregabalin - Pfizer still in pain, but Swiss claims re-interpreted again Reviewed by Darren Smyth on Monday, October 24, 2016 Rating: 5
One in the eye for Pfizer glaucoma patent policy? One in the eye for Pfizer glaucoma patent policy? Reviewed by Catherine Lee on Tuesday, February 14, 2012 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.